KoSyne NeuroTech
空山慈科技
KoSyne NeuroTech (空山慈科技) is a Shanghai-based company developing non-invasive brain-computer interface (BCI) and neuromodulation technology for clinical applications . The company was co-founded by Wang Ximing (王曦明), who remains actively involved in product development .
The company has raised a Pre-A round led exclusively by Yunqi Capital in early 2026, following DaoTong Family's (道彤投资) exclusive angel-round investment . The funding is directed toward core technology R&D, clinical translation, and global expansion . Yunqi Capital frames its investment around the view that non-invasive pathways represent a more scalable direction for BCI as the field moves from research toward real clinical value .
Wang Ximing has described the team's approach as heavily iteration-driven—one system component reportedly went through more than 30 mechanical configurations before selection—and has emphasized that every feature reflects refinement through the research-to-clinical process . The company is working on next-generation products that use EEG caps to capture real-time brain signals and time neuromodulation delivery precisely .
Related coverage in elsewhere's corpus also tracks other BCI players, including invasive-approach firm Naosi Technology (脑思科技), which BlueRun Ventures backed in a $10M+ angel round in May 2026 , and Neurodome (穹顶医疗), a Xi'an-based TI (temporal interference) neuromodulation company founded in 2019 .
AI-generated — may contain errors, please verify.
Coverage
Vol.18 The Non-Sci-Fi Story of Brain-Computer Interfaces: From Top-Tier Hospitals to Home Bedrooms, How Many Steps to Rebuild Prefrontal Order? | A Conversation with Ximing Wang of Kongshan Ci
Yunqi Capital Quarterly Q1 | Keep Moving Forward, Answers Lie Ahead
A Quick Look at Yunqi Capital's Latest
On Day 5 of Brain-Computer Interface Treatment, a Depression Patient Brought a Lollipop... This Disruptive Therapy Could Win Approval Within a Year | Daotong Family
Minhang District Media Center has launched the "**Go, to the Lab**" series, going behind the scenes at Minhang's frontline research facilities to explore breakthrough technologies. This installment visits **a DaoTong portfolio company — KoSyne NeuroTech**.
Yunqi Capital Leads Exclusive Pre-A Round in Kongshan Ci Technology, Accelerating Brain-Computer Interface Commercialization | Yunqi Capital
Mapping Out the Future of Brain Science
KoSyne NeuroTech Completes Pre-A Round to Accelerate Clinical Translation of Brain-Computer Interface Neuromodulation Platform | Tong's Family
Recently, **KoSyne NeuroTech** (hereinafter referred to as "KoSyne NeuroTech"), a **Dongtou Family company** specializing in non-invasive brain-computer interfaces and neuromodulation, announced the completion of its **Pre-A funding round** — another key milestone following Dongtou Capital's exclusive angel round investment. **This round was led exclusively by Yunqi Capital, with the proceeds to be used primarily for core technology R&D, clinical translation, and global expansion.**
